300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
InsurTech
Platforms
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Sustainability
Android
Enterprise
Community
Media (Entertainment)
Hardware
Biotech
Impact
Proptech
Transportation
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Togo
Russian Federation
Guinea
Nepal
Iran
Madagascar
Isle of Man
Romania
Pakistan
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Costa Rica
Armenia
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Moldova
Uruguay
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
France
Canada
Georgia
Denmark
Ghana
United Kingdom
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
United States
Germany
India
Indonesia
Middle East
Asia
Dominican Republic
Bermuda
Albania
Spain
Argentina
Angola
Bangladesh
Europe
Cyprus
Belgium
Barbados
Jordan
Qatar
Austria
Ethiopia
Azerbaijan
Bulgaria
Bahamas
Ecuador
Bolivia
Algeria
Faroe Islands
Estonia
Belize
Finland
Italy
Jersey
Bahrain
Belarus
Hungary
Grenada
Israel
Iceland
Liechtenstein
Cambodia
Honduras
Lithuania
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Kristen Fortney, CEO & Co-Founder at BioAge Labs

Kristen Fortney

CEO & Co-Founder @ BioAge Labs

San Francisco, United States

Kristen Fortney is a Series A investor at BioAge Labs in San Francisco focused on Software and Biopharma. Kristen Fortney is based out of United States and is the CEO & Co-Founder of BioAge Labs. Kristen Fortney attended the University of Toronto.

Total investments:
2
Last investment:
Lead investor:
0%

Last updated:

Industries Kristen Fortney invests in

SoftwareBiopharmaHealth CareLife ScienceTherapeutics

Stages Kristen Fortney invests in

Series AFunding Round

Countries Kristen Fortney invests in

United StatesUnited Kingdom

Investment Focus

Industry

  • Software 1 (50%)
  • Biopharma 1 (50%)
  • Health Care 1 (50%)
  • Life Science 1 (50%)
  • Therapeutics 1 (50%)
See all 7 industries →

Stage

  • Series A 1 (50%)
  • Funding Round 1 (50%)

Country

  • United States 1 (50%)
  • United Kingdom 1 (50%)

Investments

CompanyDescriptionRoundLinks
Bluenote Health Bluenote Health
Bluenote Health operates as an AI platform for life sciences. $10M / Dec 20, 2024
Ochre Bio Ochre Bio
Ochre Bio develops genomic medicines to rejuvenate donors' livers before transplant, so that everyone who needs a new liver gets one. They use genomics to find and shut down over-active genes driving disease and then go directly to testing therapies in discarded donor livers that keep alive outside of the body.Ochre Bio is within the heartof Oxford’s biotech innovation hub. Their scientific roots can be traced back to over 15 years leading liver genomics research and experience in bringing advanced therapies to market. $30M / Series A / Oct 10, 2022

Co-Investors

BACKED VC BACKED VC 1 deal together EIT Health EIT Health 1 deal together
Hermes-Epitek 1 deal together
Khosla Ventures Khosla Ventures 1 deal together
Lifeforce Capital Lifeforce Capital 1 deal together
LifeLink Ventures LifeLink Ventures 1 deal together
BioAge Labs

About BioAge Labs

VC Fund · Richmond, United States

BIOAGE discovers and develops drugs to treat aging and associated diseases.

BioAge Labs Contacts

NameEmailPhoneSocials
Dov Goldstein
Dov Goldstein Chief Financial Officer
Kristen Fortney
Kristen Fortney CEO & Co-Founder
Donald J. Santel Independent Director
Eric Morgen
Eric Morgen CMO / COO
George Hartman Consultant for Chemistry & Strategy

Sign up to unlock verified contacts

Unlock Contacts

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
InsurTech
Platforms
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Sustainability
Android
Enterprise
Community
Media (Entertainment)
Hardware
Biotech
Impact
Proptech
Transportation
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Togo
Russian Federation
Guinea
Nepal
Iran
Madagascar
Isle of Man
Romania
Pakistan
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Costa Rica
Armenia
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Moldova
Uruguay
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
France
Canada
Georgia
Denmark
Ghana
United Kingdom
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
United States
Germany
India
Indonesia
Middle East
Asia
Dominican Republic
Bermuda
Albania
Spain
Argentina
Angola
Bangladesh
Europe
Cyprus
Belgium
Barbados
Jordan
Qatar
Austria
Ethiopia
Azerbaijan
Bulgaria
Bahamas
Ecuador
Bolivia
Algeria
Faroe Islands
Estonia
Belize
Finland
Italy
Jersey
Bahrain
Belarus
Hungary
Grenada
Israel
Iceland
Liechtenstein
Cambodia
Honduras
Lithuania
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Kristen Fortney invest in?

Kristen Fortney invests primarily in Software, Biopharma and Health Care startups, most often at Series A and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Kristen Fortney last invest?

The most recent investment recorded for Kristen Fortney closed in Dec 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Kristen Fortney Kristen Fortney Find email